                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
<120>  THYCLOTIDES

<130>  752099

<150>  US 63/011,398
<151>  2020-04-17

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic


<220>
<221>  modified_base
<222>  (1)..(12)
<223>  a cyclopentyl residue

<220>
<221>  modified_base
<222>  (1)..(1)
<223>  thiol-dPEG24 modification

<400>  1
actttgagac ta                                                           12


<210>  2
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic


<220>
<221>  modified_base
<222>  (1)..(1)
<223>  thiol-dPEG24 modification

<220>
<221>  modified_base
<222>  (3)..(3)
<223>  a cyclopentyl residue

<220>
<221>  modified_base
<222>  (11)..(11)
<223>  a cyclopentyl residue

<400>  2
actttgagac ta                                                           12


